These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9681825

  • 1. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
    Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M, Rotter V.
    Oncogene; 1998 Jun 25; 16(25):3269-77. PubMed ID: 9681825
    [Abstract] [Full Text] [Related]

  • 2. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL, Ling YF, Lai MD.
    Anticancer Res; 2000 Jun 25; 20(1A):329-36. PubMed ID: 10769676
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T, Tofilon PJ, Schaefer TS, Parikh D, Liu TJ, Lang FF.
    Cancer Res; 2002 Feb 15; 62(4):1069-76. PubMed ID: 11861384
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C, Claudio PP, Luca AD, Cuccurese M, Howard CM, D'Esposito M, Paggi MG, Sala DL, Azzoni L, Halazonetis TD, Giordano A, Maraldi NM.
    Oncogene; 2000 Oct 19; 19(44):5098-105. PubMed ID: 11042698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL, Hicks GG, Hsieh FF, Prasher JM, Green WF, Miller MD, Eide EJ, Ruley HE.
    Oncogene; 1998 Sep 03; 17(9):1119-30. PubMed ID: 9764822
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression.
    Bossi G, Lapi E, Strano S, Rinaldo C, Blandino G, Sacchi A.
    Oncogene; 2006 Jan 12; 25(2):304-9. PubMed ID: 16170357
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels.
    Bai J, Cederbaum AI.
    J Pharmacol Exp Ther; 2006 Dec 12; 319(3):1435-43. PubMed ID: 16971506
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 20. The role of p53 in the induction of polyploidity of myelomonocytic leukemic M1/2 cells.
    Peled A, Schwartz D, Elkind NB, Wolkowicz R, Li R, Rotter V.
    Oncogene; 1996 Oct 17; 13(8):1677-85. PubMed ID: 8895513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.